Dr Oliver Worsley

CEO & Co-founder

Sequential, The Skin Microbiome Testing Co.


Prior to co-founding Sequential, Oliver completed his PhD in molecular genetics as an A*STAR scholar at the Genome Institute of Singapore, and has won multiple awards including the P&G Young Entrepreneurship Scheme; the top prize at the L’Oréal Innovation Runway, and is a scholar at the Royal Academy of Engineering. Oliver has published >150 articles for the Fierce Health publication, under John Carroll. He completed his BSc with honours in pharmacology at Edinburgh University, including six months at Leiden University Medical Centre through the Erasmus Programme.

Sequential is a pioneer in the microbiome testing world. Having initially launched the world’s first at-home, consumer skin microbiome test in 2019, and with over 4 years of R&D into the human microbiome have developed out their R&D testing and formulation platform. They are backed by the global leaders such as Innovate UK, Enterprise SG, A*STAR, Genome Institute of Singapore, SOSV, Metaplanet, Scrum Ventures, Corundum Systems Biology, and operate three independent labs in London, Singapore and NYC.